Salveen Richter
Stock Analyst at Goldman Sachs
(2.37)
# 2,499
Out of 4,893 analysts
202
Total ratings
41.96%
Success rate
-0.27%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Downgrades: Neutral | $29 | $19.07 | +52.11% | 5 | Jun 17, 2025 | |
| ELVN Enliven Therapeutics | Initiates: Buy | $37 | $22.75 | +62.64% | 1 | Jun 16, 2025 | |
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $51 → $44 | $4.35 | +911.49% | 4 | May 9, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Neutral | $53 → $47 | $59.00 | -20.34% | 4 | May 8, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $15 → $13 | $9.54 | +36.27% | 3 | May 8, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $124 → $104 | $58.82 | +76.81% | 1 | May 5, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $37 → $41 | $25.88 | +58.42% | 2 | May 2, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $12 → $9 | $6.30 | +42.86% | 2 | May 2, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $9 → $10 | $12.08 | -17.22% | 11 | May 2, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $917 → $804 | $559.76 | +43.63% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $135.33 | +45.57% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $36 → $32 | $19.53 | +63.85% | 8 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $3.73 | +382.57% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $114.54 | -16.19% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $99 → $51 | $34.28 | +48.77% | 10 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $15.35 | +160.59% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $12.16 | -1.32% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $20 | $14.88 | +34.41% | 7 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $70.34 | -0.48% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $198 → $370 | $322.58 | +14.70% | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $31.04 | +144.88% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $33 → $37 | $42.38 | -12.69% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $19 → $11 | $9.21 | +19.50% | 11 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $53 | $39.57 | +33.94% | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $300.37 | +16.52% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $479.53 | +16.57% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $14.65 | -65.87% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.26 | +2,360.32% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $286.11 | -21.36% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $4.69 | +369.08% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.70 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.83 | +521.12% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $5.72 | +57.48% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $2.55 | +17.65% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $15 → $12 | $22.06 | -45.60% | 8 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $4.06 | +47.78% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $62.56 | -31.27% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $1.65 | +21.21% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $9.54 | +948.77% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $30 | $0.40 | +7,447.17% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $99.22 | -49.61% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $18.86 | +138.60% | 1 | Mar 17, 2020 |
Sarepta Therapeutics
Jun 17, 2025
Downgrades: Neutral
Price Target: $29
Current: $19.07
Upside: +52.11%
Enliven Therapeutics
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $22.75
Upside: +62.64%
4D Molecular Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $51 → $44
Current: $4.35
Upside: +911.49%
CRISPR Therapeutics AG
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $59.00
Upside: -20.34%
Arcus Biosciences
May 8, 2025
Maintains: Neutral
Price Target: $15 → $13
Current: $9.54
Upside: +36.27%
BioMarin Pharmaceutical
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $58.82
Upside: +76.81%
Summit Therapeutics
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $25.88
Upside: +58.42%
Amicus Therapeutics
May 2, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $6.30
Upside: +42.86%
Adaptive Biotechnologies
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $12.08
Upside: -17.22%
Regeneron Pharmaceuticals
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $559.76
Upside: +43.63%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $135.33
Upside: +45.57%
Mar 3, 2025
Maintains: Neutral
Price Target: $36 → $32
Current: $19.53
Upside: +63.85%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $3.73
Upside: +382.57%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $114.54
Upside: -16.19%
Jan 29, 2025
Downgrades: Neutral
Price Target: $99 → $51
Current: $34.28
Upside: +48.77%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $15.35
Upside: +160.59%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $12.16
Upside: -1.32%
Dec 12, 2024
Maintains: Neutral
Price Target: $9 → $20
Current: $14.88
Upside: +34.41%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $70.34
Upside: -0.48%
Aug 16, 2024
Upgrades: Buy
Price Target: $198 → $370
Current: $322.58
Upside: +14.70%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $31.04
Upside: +144.88%
Aug 2, 2024
Maintains: Sell
Price Target: $33 → $37
Current: $42.38
Upside: -12.69%
Jul 26, 2024
Maintains: Neutral
Price Target: $19 → $11
Current: $9.21
Upside: +19.50%
Jun 4, 2024
Maintains: Neutral
Price Target: $33 → $53
Current: $39.57
Upside: +33.94%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $300.37
Upside: +16.52%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $479.53
Upside: +16.57%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $14.65
Upside: -65.87%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.26
Upside: +2,360.32%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $286.11
Upside: -21.36%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $4.69
Upside: +369.08%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $9.70
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $4.83
Upside: +521.12%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $5.72
Upside: +57.48%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $2.55
Upside: +17.65%
Nov 4, 2022
Downgrades: Sell
Price Target: $15 → $12
Current: $22.06
Upside: -45.60%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $4.06
Upside: +47.78%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $62.56
Upside: -31.27%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $1.65
Upside: +21.21%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $9.54
Upside: +948.77%
Mar 4, 2021
Upgrades: Buy
Price Target: $28 → $30
Current: $0.40
Upside: +7,447.17%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $99.22
Upside: -49.61%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $18.86
Upside: +138.60%